INmune Bio

INMB · NASDAQ

$1.60+$0.06 (+3.90%)TodayMarket closed ·
Prev close $1.54

Who owns INMB

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 20.1% of INMB’s shares.

  • Lowdell (Mark William)5.7%
  • Moss (David J.)4.9%
  • Vanguard Capital Management, LLC2.7%
  • AQR Capital Management, LLC2.5%
  • Next 6 largest institutions4.4%
  • All other shareholders79.9%
Top institutional holders of INMB
HolderShares% of shares
Lowdell (Mark William)1.52M5.71%
Moss (David J.)1.29M4.87%
Vanguard Capital Management, LLC706.42K2.66%
AQR Capital Management, LLC662.22K2.49%
BlackRock Institutional Trust Company, N.A.305.01K1.15%
Raymond James Financial Services Advisors, Inc.212.83K0.80%
Geode Capital Management, L.L.C.190.22K0.72%
Millennium Management LLC159.56K0.60%
Susquehanna International Group, LLP158.45K0.60%
Jane Street Capital, L.L.C.134.23K0.50%

Largest mutual fund holders

Top mutual fund holders of INMB
HolderShares% of shares
Vanguard Total Stock Market Index Fund490.27K1.84%
Vanguard Extended Market Index Fund196.00K0.74%
Fidelity Extended Market Index Fund189.55K0.71%
Rhenman Healthcare Equity L/S178.28K0.67%
iShares Micro-Cap ETF82.66K0.31%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of INMB in the last 6 months.

Latest INMB insider transactions
InsiderTypeSharesValue
SAPIRSTEIN JAMESAward100.00K—
Clark Ronnie DuaneAward100.00K—
Juda ScottOption exercise14.80K$1.85K
Juda ScottOption exercise14.80K$20.72K
Lowdell Mark WilliamOption exercise7.21K$901
Lowdell Mark WilliamOption exercise7.21K$10.10K
Moss David JOption exercise9.01K$1.13K
Moss David JOption exercise9.01K$12.62K

Short interest

Settled Sep 30, 2026

Shares short
2.66M
Days to cover
6.96
% of shares outstanding
10.00%
Average daily volume
381.62K
Change since last report
+18.1%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.